Browsing the "RusnanoMedInvest" Tag →

02 2014 September
By FinSMEs
0 Comments

Clearside Biomedical Closes $16M Series B Financing

Clearside Biomedical, Inc., an Alpharetta, GA-based clinical-stage biopharmaceutical company, closed a $16m Series B financing. Backers included new investor RusnanoMedInvest...

Read More →
25 2014 August
By FinSMEs
0 Comments

Aldea Pharmaceuticals Closes $24m Series B Equity Financing

Aldea Pharmaceuticals, a Redwood City, CA-based developer of novel therapeutics to treat aldehyde metabolism disorders, closed a $24m Series B...

Read More →
30 2014 July
By FinSMEs
0 Comments

Epic Sciences Completes $30M Series C Financing

Epic Sciences, Inc., a San Diego, CA-based biotech company that designs and develops novel diagnostics to personalize and advance the...

Read More →
12 2014 February
By FinSMEs
0 Comments

Miramar Labs Raises $10M in Series D Funding

Miramar Labs®, Inc., a Sunnyvale, CA-based medical device manufacturer focused on the treatment of excessive underarm sweat, raised $10m in...

Read More →
03 2013 October
By FinSMEs
0 Comments

NovaDigm Therapeutics Closes $14M Series B Financing

NovaDigm Therapeutics, a Grand Forks, North Dakota-based developer of vaccines for fungal and bacterial infections, closed a $14m Series B...

Read More →
27 2013 August
By FinSMEs
0 Comments

Syndax Pharmaceuticals Secures $26.6M Series B Financing

Syndax Pharmaceuticals Inc., a Waltham, MA-based developer of epigenetic therapies for treatment-resistant cancers, secured a $26.6m Series B financing. Backers included...

Read More →
29 2013 July
By FinSMEs
0 Comments

ReVision Optics Raises $55M in Equity Financing

ReVision Optics, Inc., a Lake Forest, CA-based developer of implantable corneal inlay technology to treat presbyopia, raised $55m in equity...

Read More →
07 2013 January
By FinSMEs
0 Comments

Marinus Pharmaceuticals Raises $21M Funding in Series C Financing

Marinus Pharmaceuticals, Inc., a Branford, Conn.-based developer of a neuroactive steroid, raised an additional $21m funding in Series C financing....

Read More →
19 2012 December
By FinSMEs
0 Comments

Regado Biosciences Secures $51M in Series E Financing

Regado Biosciences, Inc., a Basking Ridge, New Jersey-based developer of antithrombotic aptamers with active control agents, has secured $51m in...

Read More →
26 2012 July
By FinSMEs
0 Comments

CoDa Therapeutics Raises $20M in Second Closes Series B Financing

CoDa Therapeutics, Inc., a San Diego, CA-based clinical stage biotechnology company focused on developing novel targeted therapies for inflammation, wound-healing...

Read More →